Searched for
GLIVEC
Why was Novartis denied a patent for Glivec in India?If Novartis had won the case, it would have been granted a monopoly on Glivec, and denied Indian companies the right to make the drug.02 Apr, 2013, 11.13 AM IST- Novartis wants Indian patent system to improve, compares with ChinaWe will continue with our investments in India, though cautiously. We hope that the ecosystem for intellectual property improves, Ranjit Sh...01 Apr, 2013, 03.40 PM IST
- Novartis condemns Supreme Court's patent bid for cancer drugNovartis condemned the Supreme Court's dismissal of its patent bid for a blockbuster cancer drug, saying it "discourages future innovation".01 Apr, 2013, 02.18 PM IST
- Novartis loses legal battle over Glivec, huge boost for local drug cosNovartis' Glivec is priced at Rs 1.2 lakh whereas local generic versions, which feed most of the poor countries of the world, cost a fourth...01 Apr, 2013, 12.33 PM IST
- Novartis fears it may lose Glivec case in Supreme CourtThe Supreme Court is slated to announce a verdict in the case filed by Novartis in 2006 against the Indian government, challenging a key pu...28 Mar, 2013, 05.54 AM IST
- Supreme Court questions Novartis' patent claim on GlivecNovartis appeared to suffer a setback in the Supreme Court in its attempt to obtain a patent for its anti-leukemia drug Glivec when the cou...31 Oct, 2012, 06.00 AM IST
- Protests in US over high pricing of Novartis' anti-cancer drug GlivecOver 300 petitioners have demanded that the Obama administration force Novartis to cut the price of Glivec, which they say is too high.15 May, 2012, 11.32 AM IST
- Novartis India keeps fingers crossed as SC hears glivec patent caseThe Indian subsidiary of Swiss drug maker Novartis is making a final attempt at getting a patent for its anti-cancer drug Imatinib with the...05 Mar, 2012, 07.07 AM IST
- Novartis moves SC in Glivec patent caseSwiss major Novartis AG has moved the Supreme Court challenging Intellectual Property Appellate Board (IPAB) decision to reject its patent ...29 Aug, 2009, 04.18 AM IST
- HC breather for Novartis in Glivec patent appealThe Madras High Court has cleared a government proposal to exclude a technical member of the Intellectual Property Appellate Board (IPAB) f...14 Nov, 2007, 06.18 AM IST
- Govt moves new proposal before HC on Glivec caseThe government has submitted a new proposal with the Madras High Court to let the chairman and vice-chairman of the Intellectual Property A...09 Oct, 2007, 03.17 AM IST
- HC to hear Novartis case on October 8The Madras High Court will hear on October 8, Novartis' objection to the appointment of S Chandrasekaran, former Controller General of the ...11 Sep, 2007, 04.21 AM IST
- HC suspends hearings in Novartis' Glivec caseHearings in Novartis’ appeal against the rejection of patent for its anti-cancer drug Glivec have been suspended yet again, after the Madra...10 Aug, 2007, 01.26 AM IST
- Glivec patent appeal's pendingNovartis has lost its challenge against the Indian government on the question of patent for incremental innovation, but its specific appeal...07 Aug, 2007, 01.36 AM IST
- IPAB hears Novartis’ objection against S ChandrasekaranThe Indian Patent Appellate Board (IPAB) on Monday heard a case that will decide whether S Chandrasekaran, former controller general of pat...03 Jul, 2007, 04.16 AM IST
- Novartis hits a blind spot with Glivec appealIn a new twist to the globally-publicised Glivec case, Novartis has objected to the appointment of the former controller general of patents...19 Jun, 2007, 04.20 AM IST
- Novartis takes on patent law in Glivec caseFollowing rejection of its patent application for anti-cancer drug Glivec, Swiss pharmaceutical giant Novartis AG is not only challenging t...30 Jan, 2007, 01.30 AM IST
Load More
